Side-by-side matrix of up to 4 real life-sciences investors — the four deterministic scoring engines, fund and portfolio metrics, syndicate behaviour, and stage, thesis, technical-interest and diligence matrices, with the best value in each numeric row highlighted.
Scores deterministic, rules-based — not AI. Nothing here is investment advice or a recommendation to approach any firm.
Manufacturing focusiHow much of the firm's stated interest sits in manufacturing rather than discovery — scored from its technical interests, strategic categories and its explicit GMP-manufacturing interest flag.
19
54
Portfolio strengthiHow the firm's recorded portfolio has performed — scored across its portfolio companies from how many are active against how many reached an IPO, acquisition or other exit.
52
45
Syndicate strengthiHow established the firm's co-investment network is — scored across its recorded co-investors from the mix of investor types, the number of shared deals and how frequent each relationship is.
77
56
Manufacturing diligenceiHow deeply the firm can assess a manufacturing asset — scored from the depth recorded against each diligence area (CMC strategy, sterility assurance, contamination control, validation and the rest) plus its regulatory frameworks, technical-DD capability and whether it reviews inspection history.
67
99
Capability scores are a directional starting point, not a verdict. A lower score does not disqualify a company or consultant, and no decision should rest on the score alone — always contact the company directly to confirm the specifics for your project.
Illustrative firm data · not investment advice, not a recommendation, and not a solicitation. Scores describe declared focus and recorded activity, not returns. All scoring is deterministic and rules-based; no AI/ML inference is involved.
ComparingOrbiMedSofinnova Partners
Best in row · deterministic, rules-based — not AI · illustrative seed data